Results 1 to 10 of about 21,002 (290)

Near-Infrared Laser Adjuvant for Influenza Vaccine [PDF]

open access: yesPLoS ONE, 2013
Safe and effective immunologic adjuvants are often essential for vaccines. However, the choice of adjuvant for licensed vaccines is limited, especially for those that are administered intradermally.
Brauns, Timothy   +21 more
core   +5 more sources

Liposomes as Immunological Adjuvants [PDF]

open access: yesNature, 1974
ADJUVANTS are widely used to increase antibody formation in experimental animals, for example, Freund's incomplete adjuvant, a water-in-oil emulsion containing the antigen, and Freund's complete adjuvant, which is the same but with killed tubercle bacilli.
Allison, A C, Gregoriadis, G
openaire   +4 more sources

Analogue peptides for the immunotherapy of human acute myeloid leukemia [PDF]

open access: yes, 2015
Accepted manuscript. The final publication is available at: http://link.springer.com/article/10.1007%2Fs00262-015-1762-9The use of peptide vaccines, enhanced by adjuvants, has shown some efficacy in clinical trials.
A Driessche Van   +102 more
core   +1 more source

Immunological adjuvants in allergy vaccines: Past, present future [PDF]

open access: yes, 2001
Hundreds of compounds have been tested over the years in a search for adjuvants to incorporate with antigens or allergens to enhance the immune response.
Wheeler, Alan W., Woroniecki, Stefan R.
core   +1 more source

Immunology and efficacy of MF59-adjuvanted vaccines [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Adjuvants are included in vaccine formulations to enhance the immunogenicity and efficacy of vaccines. MF59® is an oil-in-water emulsion adjuvant and licensed for use in pandemic and seasonal influenza vaccines in many countries. MF59 is safe and well tolerated in humans.
Eun-Ju Ko, Sang-Moo Kang
openaire   +4 more sources

Nanoparticulate adjuvants and delivery systems for allergen immunotherapy [PDF]

open access: yes, 2012
In the last decades, significant progress in research and clinics has been made to offer possible innovative therapeutics for the management of allergic diseases. However, current allergen immunotherapy shows limitations concerning the long-term efficacy
Esparza, I. (Irene)   +5 more
core   +6 more sources

Innate immunity: ignored for decades, but not forgotten. [PDF]

open access: yes, 2012
The innate immune system must recognize and rapidly respond to microbial pathogens, providing a first line of host defense. This is accomplished through an array of pattern recognition receptors (PRRs) that reside in specific subcellular compartments and
Adam   +53 more
core   +1 more source

Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions [PDF]

open access: yes, 2010
The goal of cancer vaccines is to induce antitumor immunity that ultimately will reduce tumor burden in tumor environment. Several strategies involving dendritic cells- (DCs)- based vaccine incorporating different tumor-associated antigens to induce ...
Gong, Jianlin   +10 more
core   +4 more sources

Gr1+IL-4-producing innate cells are induced in response to Th2 stimuli and suppress Th1-dependent antibody responses [PDF]

open access: yes, 2008
Alum is used as a vaccine adjuvant and induces T<sub>h</sub>2 responses and T<sub>h</sub>2-driven antibody isotype production against co-injected antigens.
A. S. McKee   +45 more
core   +1 more source

What's new in the diagnosis and management of food allergy in children? [PDF]

open access: yes, 2013
This article reviews the recent advances in the diagnosis and management of IgE mediated food allergy in children. It will encompass the emerging technology of component testing; moves to standardization of the allergy food challenge; permissive diets ...
Campbell, DE, Turner, PJ
core   +1 more source

Home - About - Disclaimer - Privacy